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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYThe mammalian heart has generally been considered nonregenerative, but recent progress suggests that neonatal mouse hearts have a
genuine capacity to regenerate following apex resection (AR). However, in this study, we performed AR or sham surgery on 400 neonatal
mice from inbred and outbred strains and found no evidence of complete regeneration. Ideally, new functional cardiomyocytes, endo-
thelial cells, and vascular smooth muscle cells should be formed in the necrotic area of the damaged heart. Here, damaged hearts were
9.8% shorter and weighed 14% less than sham controls. In addition, the resection border contained a massive fibrotic scar mainly
composed of nonmyocytes and collagen disposition. Furthermore, there was a substantial reduction in the number of proliferating car-
diomyocytes in AR hearts. Our results thus question the usefulness of the AR model for identifying molecular mechanisms underlying
regeneration of the adult heart after damage.INTRODUCTION
A key question in cardiovascular biology is to what degree
the heart is able to regenerate after tissue damage from
either cardiac stem cells or cardiomyocyte division. Cardio-
vascular disease including myocardial infarct is currently
one of the leading causes of death worldwide, and the gen-
eral view is that this is mainly caused by a genuine inability
of themammalian heart to regenerate upon damage (Vieira
and Riley, 2011). Yet, this dogma was recently challenged
by exciting data suggesting that the mouse heart retains
regenerative ability up to 1 week after birth (Porrello
et al., 2011), and without being reproduced by others, it
has now been accepted as an established principle that
neonatal mammalian hearts do enclose a true cardiac-
regenerative potential following apex resection (AR)
(Aguirre et al., 2013; Garbern and Lee, 2013). As a minimal
requirement, complete cardiac regeneration should
include the restoration of the functional continuity of car-
diomyocytes, as well as blood supply in the necrotic area of
the damaged heart with no sign of scar formation. Indeed,
urodele amphibians and zebrafish have been shown to
possess a high capacity to repair the heart following dam-
age such as AR that meets these minimal criteria (Garbern
et al., 2013). Accordingly, the zebrafish heart is regenerated
in 60 days following AR, with full recovery of the myocar-
dium (Poss et al., 2002). The mammal and zebrafish heart
anatomy/physiology diverge substantially (Garbern et al.,
2013). It was therefore a breakthrough in regenerativemed-
icine of the mammalian heart when Porrello et al. in 2011
showed that the neonatal mouse heart (1 day old) holds an406 Stem Cell Reports j Vol. 2 j 406–413 j April 8, 2014 j ª2014 The Authorintrinsic capability to regenerate completely following
resection of 10% of the heart apex (Porrello et al., 2011).
As in the zebrafish heart (Jopling et al., 2010), the regener-
ative response in mice was primarily accomplished
through reentry of cardiomyocytes into the cell cycle
(Porrello et al., 2011). Interestingly, this ability was only
transient and lost by postnatal day 7 (P7) (Porrello et al.,
2011), a scenario the authors most recently suggested is
caused by the homeobox transcription factor Meis1 inhib-
iting cardiomyocyte proliferation (Mahmoud et al., 2013).
Remarkably, the repairing response seems to be faster
in mice (21 days) (Porrello et al., 2011) than in teleost
fish (60–180 days) (Lafontant et al., 2012; Poss et al.,
2002). Furthermore, the regenerated neonatal mouse
heart reportedly showed no signs of major scarring after
21 days (Porrello et al., 2011), which is in contrast to the
mammalian adult heart that lacks substantial regenerative
capacity (Garbern et al., 2013; Vieira and Riley, 2011). In
addition, urodele amphibians and teleost fish show sub-
stantial scarring up until 60–180 days postinjury (Lafont-
ant et al., 2012; Oberpriller and Oberpriller, 1974; Poss
et al., 2002).
The reported availability of the neonatal mouse heart
regeneration model is thus extremely valuable to re-
searchers in order to identify factors that may be used for
improving regeneration of the adult heart in the large
group of patients suffering from cardiac infarcts. We thus
originally set out to identify factors enabling regeneration
of the heart. However, our data do not yield evidence of a
complete regenerative response in the neonatal mouse
heart following AR.s
Figure 1. C57Bl/6 Neonatal Mouse
Hearts Do Not Regenerate following AR
(A) Open thoracotomy was used to re-
move 5%–10% of the heart apex from hy-
pothermia-anesthetized neonatal C57Bl/6
mice.
(B and C) Hearts from sham (n = 21) and
apex-resected (n = 23) mice were removed
immediately after AR and weighed to
determine the amount of resected heart
tissue. Hematoxylin staining of AR hearts
(n = 10) confirmed localization of the re-
sected area. Black line indicates resection
border. LV, left ventricle.
(D) Animal survival was determined imme-
diately (0 hr), then 3 and 24 hr after
surgery.
(E) The cardiac weight in sham and AR
animals was determined at different time
points following surgery. Two-way ANOVA
was used to test significance (****p <
0.0001 for weight over time).
(F) Relative cardiac height at day 21 in
sham (n = 5) and AR (n = 7) hearts. Stu-
dent’s t test was used to test significance
(*p < 0.05).
(G) Three representative stereomicroscopic
pictures of sham and AR hearts.
(H) Representative HE stainings from three to six sham or AR hearts at day 21 or 37 that enclose the AR damage. All hearts (n = 16) were
sectioned throughout and examined (see Figure S1) to identify the area of apex lesion marked by an asterisk (*).
See also Figure S1.
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Establishing the AR Model in Inbred C57Bl/6 Mice
The study by Porrello et al. was performed in the out-
bred ICR/CD-1 mouse strain (Porrello et al., 2011).
However, many transgenic mouse models including
ours use inbred mouse strains. We therefore set out to
clarify and evaluate the regenerative potential of AR
hearts in C57Bl/6 mice. We used the exact same
surgery protocol (Figure 1A) as described previously
by Porrello et al. (2011) for AR. The heart-to-body
weight was reduced by 8.4% in AR hearts as compared
with sham hearts immediately following resection (Fig-
ures 1B and 1C). The average resection size is thus
similar to the approximate 10% accomplished by Porrello
et al. (2011). Supportive of that, we achieved a 90%
survival of AR animals following surgery, whereas
maternal cannibalization further lowered this to 80%–
85% (Figure 1D), which is moderately higher than the
70% survival reported for ICR/CD-1 mice (Porrello
et al., 2011). Thus, our surgery setup for AR in C57BL/6
mice seems comparable to that reported for the ICR/
CD1 mice.StemNeonatal C57Bl/6 Mice Do Not Regenerate Their
Hearts following AR
Unexpectedly, however, we found that the AR heart
weights were compromised throughout the study, with a
persistent 14% reduction in AR hearts at day 21 (Figure 1E).
Additionally, the resected hearts were 9.8% shorter at day
21 than sham controls (Figures 1F and 1G). These results
thus indicated that the apex was healed but not regener-
ated with healthy tissue replenishing the removed apex.
In accordance, stereomicroscopic (Figure 1G) and histolog-
ical (Figure 1H; Figure S1 available online) examinations of
AR and shamhearts showed an extensive remodeling of the
damaged area in 100% of AR hearts at day 21, which was
absent in sham specimens. Of note, scars were observed
in 15.7% ± 4.1% of hematoxylin and eosin (HE)-stained
sections (778 ± 54 per heart; n = 7). These data thus surpris-
ingly suggested that C57BL/6 hearts were unable to
regenerate.
Apex-Resected C57Bl/6 Hearts Are Healed with
Accumulation of Many Noncardiomyocytes
An extensive quantitative real-time PCR study showed
that mesenchymal, fat, hematopoietic, and vascular geneCell Reports j Vol. 2 j 406–413 j April 8, 2014 j ª2014 The Authors 407
Figure 2. C57Bl/6 Hearts Become Sub-
stantially Fibrotic following AR and
Show Signs of Hypertrophy
(A) Quantitative real-time PCR of sham and
AR hearts (n = 4) at indicated time points.
Statistical significance tested by two-way
ANOVA is indicated.
(B and D) Paraffin- and cryo-embedded
C57Bl/6 AR hearts (n = 4–8) were sectioned
and immunostained for (B) CD45/non-
muscle myosin and (D) desmin/collagen;
cardiac myosin; nonmuscle myosin/CD31.
Representative images were processed
(contrast/brightness and color balance)
equally in Adobe Photoshop to enable
merging. An asterisk (*) indicates lesion
area, whereas white arrows reflect the
AR line.
(C) Sirius Red stainings of representative
sham (n = 5) and AR (n = 11) heart sections
from C57Bl/6 mice identify collagen
disposition in the lesioned apex.
(E) Quantitative real-time PCR for hyper-
trophic markers (ANP and BNP) of sham and
AR hearts (n = 4) at indicated time points.
(F) The relative width of C57Bl/6 hearts
from sham and AR animals was measured
at day 21. Significance was tested by a
Student’s t test (*p < 0.05).
For (A) and (E), quantitative real-time
PCR raw data were normalized against B2M
and b-actin, which were stably expressed
as determined by the qBase+ platform
(M:0.579 and CV:0.202) (Hellemans et al.,
2007; Vandesompele et al., 2002).
See Figure S2 for quantitative real-time PCR
profiling on gene programs at day 21
following AR.
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as compared to sham hearts (Figure S2), whereas epicardial
and cardiomyocyte gene programs overall remained un-
changed at this endpoint (Figure S2). Hematopoietic cells
such as macrophages are responsible for cleaning up
necrotic constituents in areas of heart damage but are
also main drivers of cardiac fibrosis (Santini and Rosenthal,
2012). We found increasing mRNA levels of Cd45, a he-
matopoietic marker (Figure 2A), already 3 hr after AR, re-
flecting an immediate influx of inflammatory cells as
confirmed by immunohistochemistry (Figure 2B). The
majority of these inflammatory cells disappeared between
days 7 and 14 (Figures 2A and 2B), but some were still
evident at day 21 in the lesioned area of AR hearts (Fig-
ure 2B). Heart fibrosis is characterized by deposition of
collagen I and a transition of cardiac fibroblasts to myofi-
broblasts secreting large amounts of fibronectin. We found408 Stem Cell Reports j Vol. 2 j 406–413 j April 8, 2014 j ª2014 The Authorthe inflammatory response in AR hearts to be clearly
accompanied by an increase in both Pro-collagen I and
Fibronectin (Figure 2A). This was confirmed by substantial
amounts of collagen in the lesioned area as visualized by
Sirius Red staining (Figure 2C) and immunohistochemistry
(Figure 2D). In contrast to sham hearts, 100% of AR
hearts contained numerous noncardiomyocytes (cardiac
myosin/desmin/nonmuscle myosin+, collagen I+) in
the apex (Figure 2D). Moreover, mRNAs for Atrial Natri-
uretic Peptide (ANP) and Brain Natriuretic Peptide (BNP), two
markers of cardiac damage and hypertrophy, were
increased in the AR hearts (Figure 2E) with a concomitant
7.5% increase in cardiac width (Figure 2F), the latter
possibly indicating hypertrophic growth. Together, these
data demonstrated that resection of heart muscle in neo-
nates induced a massive fibrotic response resulting in sub-
stantial scarring at day 21.s
Figure 3. The Apex-Resected Zone in
C57Bl/6 Hearts Reveals Limited Vascu-
larization and Numbers of Proliferating
Cardiomyocytes
(A) Cryosectioned C57Bl/6 AR hearts (n =
4–8) were immunostained for aSMA, CD31,
and NG2/CD31. Representative images were
processed (contrast/brightness and color
balance) equally in Photoshop to enable
merging. An asterisk (*) indicates lesion
area, whereas a number sign (#) refers to
nondamaged myocardium.
(B) Quantitative real-time PCR for Cd31 of
sham and AR hearts (n=4) at indicated
time points. Quantitative real-time PCR raw
data were normalized against the stably
expressed B2M and b-actin genes (see
Figure 2).
(C–F) Paraffin-embedded C57Bl/6 AR and
sham hearts (n = 5) from EdU pulse-chase
labeled animals were sectioned and immu-
nostained for EdU/cardiac myosin/collagen
I/DAPI to enable identification of prolifer-
ating cells in total and proliferating
cardiomyocytes specifically. Images were
taken in four different zones (white boxes
in C and areas magnified in F) of each heart
and used for cell number quantification
(D and E) as described in Experimental
Procedures.
(G) Quantitative real-time PCR for Meis1b of
sham and AR hearts (n = 4) at indicated
time points. Quantitative real-time PCR raw
data were normalized against the stably
expressed B2M and b-actin genes (see Fig-
ure 2).
(H) Meis1b is downregulated with cardiac
development. Hearts were microdissected
from C57Bl/6 mice at indicated time points
and used for quantitative real-time PCR.
Primers used were previously described by
Mahmoud et al. (2013). Each biological
experiment (n = 3–6) included between
one and six hearts. qPCR raw data were
normalized against Gapdh and b-actin,
which were stably expressed as determined
by the qBase+ platform (M:0.306, CV: 0.106) (Hellemans et al., 2007; Vandesompele et al., 2002). Statistical significance was tested
using a one-way ANOVA with a Dunnett’s multiple comparison posttest. E11.5, embryonic day 11.5.
Stem Cell Reports
The Neonatal Mammalian Heart: Regenerative or Not?The Damaged Apex Comprises Modest
Vascularization, but Few Proliferating
Cardiomyocytes
Ideally, cardiac regeneration should be able to restore the
functional continuity of cardiomyocytes, as well as blood
supply (endothelial and smooth muscle cells) in the
necrotic area of the damaged heart. We did encounter
blood vessels with CD31+ endothelia, and surroundingStemsmooth muscle cells (aSMA+ and NG2+) in the lesioned
area (Figures 2D and 3A). These vessels may either be preex-
isting vessels developed in the border zone prior to lesion,
but they may also represent newly formed vascularity in
the damaged area because both Cd31 (Figure 2B) and
numerous other vascular genes (Figure S2) were increased
in AR hearts as compared with sham controls. Yet, the
vascularization was still incomplete as compared withCell Reports j Vol. 2 j 406–413 j April 8, 2014 j ª2014 The Authors 409
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rello et al. suggest that the regenerative heart response is
due to an increased number of cardiomyocytes undergoing
division 1–7 days following AR (Porrello et al., 2011). We
therefore quantified the total number of proliferating cells
(5-ethynyl-2-deoxyuridine positive [EdU+]) as well as the
number of proliferating cardiomyocytes (EdU+/cardiac
myosin+/collagen I) 1–7 days postsurgery by pulse-chase
labeling experiments (Figures 3C–3F). As such, there was a
clear tendency (p = 0.06) for lower numbers of proliferating
cells in the AR hearts compared to sham hearts, and a pro-
found reduction in the overall number of dividing cardio-
myocytes throughout the heart, with remarkably few being
present in the apex area (Figures 3G and 3H). Instead, the
proliferating cells in the apex region of AR hearts (Figures
3F and 3H) were fibroblastic in phenotype (EdU+/cardiac
myosin/collagen I+) and accounted for the majority of
proliferating cells in this zone (Figure 3F). In addition, we
did not observe any difference in AR and sham hearts of
Meis1b transcripts (Figure 3G), and levels were decreasing
with normal cardiac development (Figure 3H). This contra-
dicts the suggested ability of increasing Meis1b levels to
inhibit cardiomyocyte proliferation beyond P7 (Mahmoud
et al., 2013). Therefore, our data do not support enhanced
cardiomyocyte proliferation 1–7 days following AR as pre-
viously reported by Porrello et al. (2011). To exclude that
the regeneration process merely was delayed in C57Bl/6
mice, we prolonged the examination period with 16 days,
thus analyzing the hearts histologically at day 37. Yet, the
hearts were still substantially compromised at day 37
with large visual fibrotic scars (Figures 1H, 1I, and 2C),
numerous noncardiomyocytes in the lesion area (data
not shown), and insufficient vascularization (data not
shown), further suggesting that C57Bl/6 hearts heal by re-
modeling rather than by true regeneration.
ICR/CD1 Mice Also Fail to Accomplish Complete
Regeneration of Their Hearts
Porrello et al. showed a high regenerative capacity of apex-
resected hearts in outbred ICR/CD1 mice (Porrello et al.,
2011). Although no difference in regenerative capacity
has been reported for C57Bl/6 and ICR/CD1mouse strains,
other regeneration schemes such as wound healing in the
ear are highly dependent on the strain (Heber-Katz,
1999). We therefore next performed a new series of AR in
24 ICR/CD1 mice to reevaluate the cardiac-regenerative
response recently described by Porrello et al. (2011). How-
ever, we did not find any evidence suggesting a complete
cardiac-repairing response in the neonatal heart of ICR/
CD1 mice either (Figure 4). As with the C57Bl/6 hearts,
we found substantial fibrotic scars in 21.5% ± 4.7% of
HE-stained sections (846 ± 60 per heart; n = 11), many non-
cardiomyocytes (cardiac myosin/desmin/nonmuscle410 Stem Cell Reports j Vol. 2 j 406–413 j April 8, 2014 j ª2014 The Authormyosin+/collagen I+), and an incomplete vascular network
in 100% of resected ICR/CD1 hearts at day 21 (Figures 4
and S3). These data thus suggest that the absence of com-
plete heart regeneration following heart muscle resection
is mouse strain independent.DISCUSSION
Mortality after myocardial infarction is relatively high, and
surviving patients are often severely compromised due to
insufficient heart-pump function. At the cellular level,
damage to the heart’s contractile constituents, the cardio-
myocytes, is irreversible, and treatments merely serve to
reduce symptoms, and only a minority of patients receives
a heart transplant. Novel therapeutics to reestablish the
cardiac tissue following infarcts are therefore needed, and
factors improving heart regeneration will be of enormous
value. The groundbreaking discovery of a mammalian
regenerative heart model in mice (Porrello et al., 2011)
has thus gained immense attention and hope for identi-
fying factors that may improve cardiac regeneration. How-
ever, none of our results here suggests that the neonatal
mammalian heart is able to accomplish complete regener-
ation following heart muscle resection as recently sug-
gested by Porrello et al. (2011). Instead, we demonstrate
that the resected heart apex remains lost and that the
resection border is healed by a fibrotic scar composed of
myofibroblasts, adipocytes, and sparse vessels. These non-
myogenic cells likely originate from the pericardium/
epicardium (Smart et al., 2007; Zhou et al., 2008), the
only structure in the apex that seemed completely regener-
ated. In contrast, we observed a lack of cardiac regeneration
likely caused by a reduced number of proliferating cardio-
myocytes within AR hearts as compared with noninjured
hearts. Although the absolute number of proliferating car-
diomyocytes would have been optimally determined by
quantifying a proliferation marker in combination with a
nuclear cardiomyocyte genetic label (Ang et al., 2010),
our approach using EdU with cardiac myosin/collagen I
seems valid for the relative measurements we performed,
and importantly, Porrello et al. used a similar approach
(Porrello et al., 2011). Our results are thus contradictory
to those reported in the original study performed by the
Sadek research group (Porrello et al., 2011).
We can only speculate on the reasons for the contradic-
tions between our study and the Porrello study (Porrello
et al., 2011). Importantly, we resected equal amounts of
apex tissue, an obvious key parameter that otherwise could
have influenced the outcome. Likewise, we used the same
time schedule during surgery as previously described by
Porrello et al. (2011), where the extent of hypothermia
may be critical for the heart tissue survival and therefores
Figure 4. Apex-Resected ICR/CD1 Hearts
Do Not Reveal Any Major Regenerative
Response but Become Fibrotic
Representative sham (n = 3) and AR (n = 11)
hearts from outbred ICR/CD-1 neonates
(n = 24) were analyzed at day 21 by (A)
HE staining (arrow identifies lesion), (B)
stereomicroscopy, (C) immunofluorescence,
and (D) Sirius Red staining. Representative
sections are shown (see Figure S3). For (C),
images were processed (contrast/bright-
ness and color balance) equally in Photo-
shop to enable merging.
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strains may impose another problem to the results; yet,
this seems less likely because we performed AR in both
C57Bl/6 and ICR/CD1 mice and found no difference in
scar formation at day 21. Supportive of that, the Sadek
research group as well as others have reported a regenera-
tive capacity of the heart in B6C3F1 (hybrid of C57Bl/6 3
C3H/He) (Xin et al., 2013) and C57Bl/6 (Haubner et al.,
2012) mice. Even so, ICR/CD1 mice from different
breeding facilities have been shown to diverge (Aldinger
et al., 2009), and unknown factors associated with the
mice thus cannot be absolutely excluded for having an
impact on the heart’s ability to regenerate. Finally, one
may consider the analysis procedures used in our study
and the ones performed by Porrello et al. Both studies
base a substantial amount of the results on histological ex-
aminations. Porrello et al. report in their supplemental in-
formation that they observe a small fibrotic scar in 2 out of
140 (1.4%) sections from damaged hearts (Porrello et al.,
2011). Yet, they do not describe if this accounts for each
heart examined or just a single outlier. It is also unclear
how many hearts were examined and if the 140 sections
were randomly chosen throughout the heart or in one
series. For comparison, we observed substantial scarringStemin 100% (31 out of 31) of AR hearts using histology, and
the lesioned area was present in 19.5% ± 5.2% of sections,
regardless ofmouse strain. Notably, Porrello et al. sliced 140
sections (each 5 mm) from one, day 21 heart, whereas we
obtained 820 ± 66 sections (each 5 mm). Thus, it may be
that Porrello et al. overlooked the lesioned area, which
often is located in the beginning or the end of sectioning
(Figure S1).
Our results therefore contradict that the AR model may
be used for identifying factors that enable cardiomyocyte
replenishment and improve heart regeneration following
damage. We cannot, however, eliminate the possibility
that a few cardiomyocytes are being regenerated following
AR, but the amplitude of this response, if present, may
therefore be insufficient for a complete cardiac repair.
One obvious limitation of the model seems to be the
ongoing hyperplastic and hypertrophic growth present in
the neonatal mouse hearts, which makes it difficult to
distinguish an eventual small true regenerative response
from simple developmental features. In that regard, it is
important to note that the well-recognized zebrafish heart
resection model is performed in adult animals (Jopling
et al., 2010; Lafontant et al., 2012; Poss et al., 2002) free
of immediate hyperplastic growth.Cell Reports j Vol. 2 j 406–413 j April 8, 2014 j ª2014 The Authors 411
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diac regeneration models such as the left anterior-descend-
ing (LAD) artery ligation in the neonatal myocardium
(Haubner et al., 2012; Mahmoud et al., 2013; Xin et al.,
2013) do unravel a true and complete regenerative poten-
tial of the heart. Still, we find it questionable that a full
cardiac regenerative response is accomplished in only
21 days (Mahmoud et al., 2013; Porrello et al., 2011),
and in one study (Haubner et al., 2012), after only 7 days
following LAD damage of the mouse heart. For compari-
son, Jesty et al. recently showed that cryo-injury to the
neonatal heart is associated with scar formation even after
94 days (Jesty et al., 2012), a scenario that is also seen up
until 60–180 days after cardiac injury in simpler organisms
like teleost fish (Jopling et al., 2010; Lafontant et al., 2012).
However, in a previous study, a genetic model of cardio-
myocyte ablation showed that the cardiomyocyte pool
is restored in the fetal mouse heart by enhanced prolifera-
tion of remaining cardiomyocytes (Drenckhahn et al.,
2008). One may speculate if a similar scenario could take
place after neonatal mouse heart LAD damage, whereas
the AR model lacks an intact 3D heart architecture, a
feature that likely is important to some extent for mamma-
lian regeneration to be accomplished. In summary, we
thus believe that additional clarifying data are required
from the scientific community on this controversial
matter to firmly establish whether the mammalian heart
is regenerative, otherwise our data substantiate the view
that it is not.EXPERIMENTAL PROCEDURES
A detailed version of our Experimental Procedures can be
found in the Supplemental Experimental Procedures. All animal
experiments were approved by the Danish Council for Supervi-
sion with Experimental Animals (#2011/561-1966). AR was
performed at P1 as previously described by Porrello et al.
(2011). Briefly, neonates were anesthetized by hypothermia,
and the apex was resected until left ventricle chamber expo-
sure, after which the thoracic wall and skin were sutured. Sham
mice underwent the exact same procedure without resecting
the apex of the heart. For pulse-chase labeling experiments,
mice were injected 1 day after surgery with EdU, and the
number of proliferating cardiomyocytes and cells in total was
counted after 7 days. Relative quantitative PCR (qPCR) and his-
tology were performed as previously described (Andersen et al.,
2009). All analyses comprised at least four independent experi-
ments, and statistical significance (p < 0.05) was tested as
indicated.
SUPPLEMENTAL INFORMATION
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